Cargando…

First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017–2020

Limited data are available regarding antimicrobial resistance in Neisseria gonorrhoeae strains circulating in WHO Eastern Mediterranean Region (EMR). We investigated the antimicrobial susceptibility/resistance of N. gonorrhoeae isolates to five antimicrobials (ceftriaxone, azithromycin, ciprofloxaci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Maslamani, Muna, Elmagboul, Emad Bashier Ibrahim, Puthiyottil, Aslam, Chemaitelly, Hiam, Varghese, Manoj Kizhakkepeedikayil, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al Khal, Abdullatif, Unemo, Magnus, Abu-Raddad, Laith J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890659/ https://www.ncbi.nlm.nih.gov/pubmed/35235608 http://dx.doi.org/10.1371/journal.pone.0264737

Ejemplares similares

Molecular characteristics of Neisseria meningitidis in Qatar
por: Hamed, Manal Mahmoud, et al.
Publicado: (2021)

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
por: Tayar, Elias, et al.
Publicado: (2023)

All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
por: AlNuaimi, Asma A, et al.
Publicado: (2023)

Epidemiology of respiratory infections among adults in Qatar (2012-2017)
por: Al-Romaihi, Hamad Eid, et al.
Publicado: (2019)

SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
por: Seedat, Shaheen, et al.
Publicado: (2021)

Global epidemiology of Neisseria gonorrhoeae in infertile populations: protocol for a systematic review
por: Chemaitelly, Hiam, et al.
Publicado: (2019)

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
por: Ayoub, Houssein H, et al.
Publicado: (2021)

COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2020)

HIV case reporting and HIV treatment outcomes in Qatar
por: Farag, Elmoubashar, et al.
Publicado: (2023)

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Global epidemiology of Neisseria gonorrhoeae in infertile populations: systematic review, meta-analysis and metaregression
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar’s experience
por: Bsat, Raghid, et al.
Publicado: (2022)

Middle East respiratory syndrome coronavirus infection profile in Qatar: An 8-year experience
por: Ben Abid, Fatma, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
por: Qassim, Suelen H., et al.
Publicado: (2023)

Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017)
por: Al-Romaihi, Hamad E., et al.
Publicado: (2020)

Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study
por: Nair, Arun P, et al.
Publicado: (2022)

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2022)

Covid-19 Vaccine Protection among Children and Adolescents in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020
por: Al Kuwari, Hanan M, et al.
Publicado: (2020)

Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics
por: Chemaitelly, Hiam, et al.
Publicado: (2019)

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
por: Butt, Adeel A, et al.
Publicado: (2022)

Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
por: Coyle, Peter V., et al.
Publicado: (2021)

Qatar's Response to COVID-19 Pandemic
por: Al Khal, Abdullatif, et al.
Publicado: (2020)

Satisfaction with a 2-day communication skills course culturally tailored for medical specialists in Qatar
por: Bylund, Carma L., et al.
Publicado: (2017)

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
por: Benslimane, Fatiha M., et al.
Publicado: (2021)

Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar
por: Jeremijenko, Andrew, et al.
Publicado: (2021)

Prevention of type II diabetes mellitus in Qatar: Who is at risk?
por: Christos, Paul J, et al.
Publicado: (2014)

Drug-resistant tuberculosis: an experience from Qatar
por: Ali, Maisa, et al.
Publicado: (2020)

163. Infective Endocarditis in Qatar: Risk Factors, Clinical Characteristics, Microbiology, and Outcomes
por: Zaqout, Ahmed, et al.
Publicado: (2019)

Viral Infections of the Central Nervous System in Qatar: Epidemiology, Pathogenesis and Clinical Outcomes
por: Abid, Fatma Ben, et al.
Publicado: (2017)

739. Middle East Respiratory Syndrome Coronavirus Infection Profile in Qatar: A 7-Year Retrospective Study
por: Elmaki, Nada, et al.
Publicado: (2018)

Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
por: Unemo, Magnus
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3t9ltlt1pe2kqgpbfarecgpqti